Literature DB >> 16645412

Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction.

Antonio Di Chiara1, Michal Plewka, Marika Werren, Luigi P Badano, Claudio Fresco, Paolo M Fioretti.   

Abstract

OBJECTIVE: Enzymatic estimation of infarct size is desirable in the reperfusion era, because a possible discrepancy with the observed asynergic area of the left ventricle may suggest the presence of stunned myocardium. Unfortunately, timely myocardial reperfusion produces a rapid washout of creatine kinase (CK) in blood flow, which overestimates infarct size. In this perspective, we investigated whether the mid-terminal portion of the CK time-activity curve could predict infarct size more reliably.
METHODS: Enzymatic infarct size was calculated by peak CK levels, the CK area under the curve and by single CK values, in 103 patients with a first ST-elevation myocardial infarction, and compared to the left ventricular akinetic area. The wall motion asynergy score at follow-up was considered as the actual infarct size.
RESULTS: In patients with peak CK within 10 h of symptom onset, CK levels at 30 h showed a high independent correlation (r = 0.83; P < 0.001) with infarct size. In patients with late peak CK (> 10 h), CK levels at 12 h turned out to be the best predictor of infarct size (r = 0.55; P < 0.01). At multivariate regression analysis, peak CK was the best predictor of infarct size in the whole population (r = 0.61; P < 0.001).
CONCLUSIONS: In patients with ST-elevation myocardial infarction and early peak CK, infarct size at follow-up could be better estimated with single values of the mid-terminal portion of the CK time-activity curve.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645412     DOI: 10.2459/01.JCM.0000223256.01439.1b

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  2 in total

1.  Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients.

Authors:  Samuel Robinson; Marie Follo; David Haenel; Maximilian Mauler; Daniela Stallmann; Lukas Andreas Heger; Thomas Helbing; Daniel Duerschmied; Karlheinz Peter; Christoph Bode; Ingo Ahrens; Marcus Hortmann
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

2.  Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size.

Authors:  Kazuya Koten; Satoshi Hirohata; Toru Miyoshi; Hiroko Ogawa; Shinichi Usui; Ryoko Shinohata; Mutsumi Iwamoto; Tomoki Kitawaki; Shozo Kusachi; Kosaku Sakaguchi; Tohru Ohe
Journal:  Clin Biochem       Date:  2007-10-11       Impact factor: 3.281

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.